Lioresal: Advanced Spasticity Management for Improved Mobility
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.27 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $78.40 $72.37 (8%) | 🛒 Add to cart |
| 120 | $0.77 | $104.53 $92.47 (12%) | 🛒 Add to cart |
| 180 | $0.73 | $156.80 $130.67 (17%) | 🛒 Add to cart |
| 270 | $0.71 | $235.20 $190.98 (19%) | 🛒 Add to cart |
| 360 | $0.70
Best per pill | $313.60 $250.28 (20%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.55 | $76.39 (0%) | 🛒 Add to cart |
| 60 | $2.13 | $152.78 $127.65 (16%) | 🛒 Add to cart |
| 90 | $1.98 | $229.17 $177.91 (22%) | 🛒 Add to cart |
| 120 | $1.90 | $305.56 $228.17 (25%) | 🛒 Add to cart |
| 180 | $1.83 | $458.35 $329.69 (28%) | 🛒 Add to cart |
| 270 | $1.78
Best per pill | $687.52 $480.46 (30%) | 🛒 Add to cart |
Synonyms | |||
Lioresal (baclofen) is a centrally-acting skeletal muscle relaxant specifically formulated for the management of severe spasticity. It is a first-line therapeutic agent for patients experiencing muscle stiffness, spasms, and pain resulting from neurological conditions such as multiple sclerosis, spinal cord injuries, and cerebral palsy. By acting on GABA-B receptors within the spinal cord, Lioresal effectively reduces the frequency and severity of muscle spasms, thereby enhancing functional capacity, facilitating physiotherapy, and significantly improving overall quality of life. This product card provides a comprehensive, expert overview of its pharmacological profile, clinical application, and essential safety information.
Features
- Active Pharmaceutical Ingredient: Baclofen
- Pharmacological Class: Gamma-Aminobutyric Acid (GABA) derivative; centrally-acting skeletal muscle relaxant
- Mechanism of Action: Agonist activity at GABA-B receptors, inhibiting monosynaptic and polysynaptic reflexes at the spinal cord level
- Available Formulations: Oral tablets (10mg, 20mg) and Intrathecal solution for pump delivery (50mcg/mL, 500mcg/mL, 2000mcg/mL)
- Bioavailability: Approximately 70-85% for oral administration; near 100% for direct intrathecal delivery
- Protein Binding: Minimal (approximately 30%)
- Metabolism: Hepatic, minimal first-pass effect (approximately 15%)
- Elimination Half-life: 2.5 to 4 hours for oral administration
- Excretion: Primarily renal (70-85% unchanged in urine)
Benefits
- Significant Reduction in Muscle Spasticity: Effectively decreases muscle tone, alleviating painful spasms and clonus, which allows for greater comfort and rest.
- Enhanced Functional Capacity and Mobility: By reducing hypertonia, patients often experience improved range of motion, making activities of daily living and participation in physical rehabilitation more feasible.
- Facilitation of Nursing Care and Physiotherapy: Eased muscle stiffness simplifies positioning, transfers, and hygiene care for bedbound patients and allows for more effective therapeutic exercises.
- Improved Quality of Life: The reduction in chronic pain, discomfort, and sleep disruption caused by nocturnal spasms contributes to a substantial improvement in overall patient well-being.
- Dual Administration Routes: Offers flexibility with oral therapy for generalized symptoms and highly targeted intrathecal delivery for severe, refractory spasticity with reduced systemic side effects.
Common use
Lioresal is indicated for the management of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. It is also a cornerstone therapy for spasticity due to spinal cord injuries and other spinal cord diseases (e.g., transverse myelitis, amyotrophic lateral sclerosis). Patients with spasticity of cerebral origin, such as that associated with cerebral palsy or traumatic brain injury, may also benefit from treatment. The goal of therapy is to provide symptomatic relief, not to serve as a cure for the underlying neurological disorder.
Dosage and direction
For Oral Administration (Tablets): Therapy must be initiated at a low dosage and titrated upward gradually to achieve optimal effect with minimal side effects.
- Adults: Initial dose is 5 mg administered three times daily. The dosage may be increased by 15 mg (e.g., one additional 5 mg tablet per dose) every 3 days until the desired effect is achieved. The average therapeutic range is 40-80 mg daily administered in divided doses. The total daily dose should not exceed 80 mg (20 mg q.i.d.).
- Pediatric Patients (age 12 and above): Use and dosage should be determined by a specialist. A typical starting dose is 5 mg three times daily, titrated as tolerated.
- Administration: Tablets should be taken with a glass of water, with or without food, to minimize potential gastrointestinal upset.
For Intrathecal Administration (via implanted pump):
- Reserved for severe spasticity of spinal or cerebral origin in patients unresponsive to oral baclofen or who experience intolerable CNS side effects at effective oral doses.
- Screening Dose: A bolus dose of 50 mcg is administered into the intrathecal space via lumbar puncture. Response is monitored for 4-8 hours. A positive response indicates suitability for pump implantation.
- Initial Pump Dosage: After pump implantation, the initial daily dose is usually double the effective screening dose. The dose is then slowly titrated upward by 10-30% increments every 24 hours until the desired clinical effect is achieved.
- Maintenance Dosage: The typical maintenance range is 300-800 mcg/day. Doses above 1000 mcg/day are rarely required. All management of the intrathecal pump must be performed by trained clinical specialists.
Discontinuation: Abrupt withdrawal of Lioresal, especially intrathecal therapy, can result in serious medical complications, including high fever, altered mental status, exaggerated rebound spasticity, and muscle rigidity that may advance to rhabdomyolysis and organ failure. Dose reduction must be performed gradually under strict medical supervision.
Precautions
- Renal Impairment: Baclofen is primarily excreted by the kidneys. Dosage reduction is necessary in patients with impaired renal function to prevent accumulation and toxicity.
- Seizure Disorders: Lioresal may lower the seizure threshold. Use with caution in patients with a history of epilepsy or convulsive disorders. Abrupt withdrawal may also precipitate seizures.
- Stroke Patients: Caution is advised, as these patients may have a reduced respiratory reserve. The sedative effects of baclofen could potentially exacerbate this.
- Psychiatric Disorders: Use with caution in patients with schizophrenia, confusional states, or other psychotic disorders, as symptoms may be exacerbated.
- Autonomic Dysreflexia: Patients with spinal cord injury at T6 or above should be monitored for autonomic dysreflexia, as Lioresal can mask its premonitory signs.
- Pregnancy and Lactation: Lioresal should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Baclofen is excreted in human milk; caution is advised when administering to a nursing woman.
- Operative and Driving Warning: Lioresal can cause significant drowsiness, dizziness, and blurred vision. Patients should be cautioned about operating machinery, driving automobiles, or performing hazardous tasks until they are certain the medication does not affect them adversely.
Contraindications
Lioresal is contraindicated in patients with:
- A known hypersensitivity to baclofen or any component of the formulation.
- Active peptic ulcer disease (relative contraindication due to potential for GI effects).
- For intrathecal administration: infection at the injection site, systemic infection, or those who are not candidates for implantation surgery due to other risk factors.
Possible side effect
Common side effects are often dose-related and may diminish over time. They primarily involve the central nervous and gastrointestinal systems.
- Very Common (>10%): Drowsiness, dizziness, weakness, fatigue, nausea.
- Common (1-10%): Headache, insomnia, confusion, hypotension, constipation, urinary frequency.
- Uncommon (0.1-1%): Depression, hallucinations, paresthesia, muscle pain, dry mouth, blurred vision, rash, erectile dysfunction, weight gain.
- Rare (<0.1%): Seizures, respiratory depression, syncope, elevated liver enzymes, severe hypersensitivity reactions.
Drug interaction
Lioresal has the potential to interact with other CNS depressants, amplifying sedative effects.
- Alcohol and Other CNS Depressants: Concomitant use with opioids, benzodiazepines, sedative antihistamines, barbiturates, anxiolytics, or alcohol can result in additive sedation, dizziness, drowsiness, and respiratory depression. Dose adjustments of one or both agents may be necessary.
- Antihypertensives: May potentiate the effects of antihypertensive medications, increasing the risk of hypotension.
- Levodopa/Carbidopa: Cases of mental confusion, agitation, and hallucinations have been reported with concomitant use.
- MAO Inhibitors and Tricyclic Antidepressants: May enhance the CNS depressant and hypotensive effects of baclofen.
- Drugs Affecting Renal Function: Agents that impair renal function may decrease the clearance of baclofen, increasing the risk of toxicity.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed.
- Do not double the dose to make up for a missed one, as this increases the risk of side effects.
Overdose
Overdose manifests as a profound exaggeration of Lioresal’s known pharmacological effects.
- Signs and Symptoms: Severe drowsiness progressing to light coma, lethargy, somnolence, seizures, respiratory depression, hypotonia, hyporeflexia, vomiting, diarrhea, salivation, blurred vision, and profound hypotension. Symptoms of intrathecal overdose can appear within a few hours and are more acute and severe.
- Management:
- Airway: Secure and maintain a patent airway; assist ventilation if necessary.
- Gastric Lavage/Activated Charcoal: May be considered for recent substantial oral ingestion if the patient is alert or intubated.
- Seizures: Administer IV benzodiazepines.
- Hypotension: Treat with IV fluids and vasopressors.
- Respiratory Depression: Provide mechanical ventilatory support.
- Bradycardia: Administer atropine.
- Specific Antidote: There is no specific antidote for baclofen overdose. Hemodialysis may be beneficial, especially in patients with renal impairment, as baclofen is significantly dialyzable.
- Intrathecal Overdose: Emergency intervention includes aspiration of 30-40 mL of CSF via the pump reservoir access port to reduce the drug load.
Storage
- Store at room temperature (20°C to 25°C or 68°F to 77°F), protected from light and moisture.
- Keep the medication in its original container, tightly closed, and out of reach of children and pets.
- Do not store in bathrooms or near sinks. Do not freeze.
- Properly discard any expired or unused medication.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision or for any adverse effects resulting from the use of the information contained herein.
Reviews
- Neurologist, 15 years experience: “Lioresal remains a foundational therapy in our spasticity management arsenal. The oral form is effective for many, but the intrathecal delivery system is a game-changer for severe, refractory cases. The key is slow, meticulous titration. The improvement in patient comfort and facilitation of care is often dramatic.”
- Physical Therapist: “From a rehab perspective, the difference in a patient’s tone after optimal Lioresal dosing is palpable. It allows us to work on meaningful functional goals, perform effective stretches, and improve positioning that was previously impossible due to rigidity. It’s a vital tool in our interdisciplinary approach.”
- Patient with MS: “The muscle spasms in my legs were relentless and painful, disrupting my sleep. Starting Lioresal was life-changing. The stiffness eased significantly, and the cramps are rare now. It did take a few weeks to adjust to the sleepiness, but that faded. I have my quality of life back.”
- Clinical Pharmacist: “Requires vigilant monitoring, especially regarding renal function and potential drug interactions with other CNS agents. Patient education on the dangers of abrupt discontinuation is absolutely critical. When managed correctly, its benefit-to-risk profile is excellent.”